CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 140 enrolled
Drug / intervention
Fluoro-Calcium-Phospho-Silicate based dentifrices +3 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04249336
NCT04249336Phase 3Completed

Immediate And Sustained Treatment Response Of Commercially Available BioMin F, Colgate Sensitive Pro-Relief And Sensodyne Rapid Action Dentifrices In Dentin Hypersensitivity - "A Randomized Clinical Trial"

Dow University of Health Sciences·interventional·Posted Jan 30, 2020·Updated May 11, 2021

In Brief

A Phase 3 clinical trial evaluating Fluoro-Calcium-Phospho-Silicate based dentifrices, 8% Arginine based dentifrices, and 2 other interventions for Dentin Hypersensitivity. Completed, enrolled 140 participants across 1 site.

Detailed Summary

This will be multi-centered, triple blinded, randomized, four parallel treatments assigned study to compare clinical efficacy of commercially available dentifrices with placebo for immediate and sustained relief from Dentin Hypersensitivity after short term use. Condition or disease: Dentin hypersensitivity Intervention/Treatment: Product 1; Fluoro-Calcium-Phospho-silicate based BioMin F Product 2; Pro-Argin formula based Colgate Sensitive Pro-Relief Product 3; Strontium Acetate based Sensodyne Rapid Action Product 4; Sodium Fluoride based Colgate Total

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesPakistan
Collaborators--

Timeline

Phase 3CompletedFinished
2020202120222023202420252026
First PostedJan 30, 2020
Enrollment StartSep 27, 2019
Primary CompletionJan 16, 2021
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 6.4 years ago

Interventions

Fluoro-Calcium-Phospho-Silicate based dentifricesdrug

Bio-Active glass based formulation

8% Arginine based dentifricesdrug

Tubular occluding formulation

8% Strontium Acetatedrug

Tubular occluding formulation

Sodium Fluoridedrug

No claim of relieving Dentin Hypersensitivity